1. Home
  2. MIST vs NAAS Comparison

MIST vs NAAS Comparison

Compare MIST & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • NAAS
  • Stock Information
  • Founded
  • MIST 2003
  • NAAS 2019
  • Country
  • MIST Canada
  • NAAS China
  • Employees
  • MIST N/A
  • NAAS N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • NAAS Other Specialty Stores
  • Sector
  • MIST Health Care
  • NAAS Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • NAAS Nasdaq
  • Market Cap
  • MIST 89.8M
  • NAAS 8.3M
  • IPO Year
  • MIST N/A
  • NAAS 2017
  • Fundamental
  • Price
  • MIST $1.94
  • NAAS N/A
  • Analyst Decision
  • MIST Strong Buy
  • NAAS
  • Analyst Count
  • MIST 2
  • NAAS 0
  • Target Price
  • MIST $7.50
  • NAAS N/A
  • AVG Volume (30 Days)
  • MIST 566.2K
  • NAAS 1.6M
  • Earning Date
  • MIST 08-07-2025
  • NAAS 07-23-2025
  • Dividend Yield
  • MIST N/A
  • NAAS N/A
  • EPS Growth
  • MIST N/A
  • NAAS N/A
  • EPS
  • MIST N/A
  • NAAS N/A
  • Revenue
  • MIST N/A
  • NAAS $43,258,393.00
  • Revenue This Year
  • MIST N/A
  • NAAS $19.53
  • Revenue Next Year
  • MIST N/A
  • NAAS $151.36
  • P/E Ratio
  • MIST N/A
  • NAAS N/A
  • Revenue Growth
  • MIST N/A
  • NAAS 50.34
  • 52 Week Low
  • MIST $0.63
  • NAAS $0.60
  • 52 Week High
  • MIST $2.75
  • NAAS $41.80
  • Technical
  • Relative Strength Index (RSI)
  • MIST 65.73
  • NAAS 34.60
  • Support Level
  • MIST $1.86
  • NAAS $0.60
  • Resistance Level
  • MIST $1.97
  • NAAS $0.84
  • Average True Range (ATR)
  • MIST 0.10
  • NAAS 0.12
  • MACD
  • MIST 0.00
  • NAAS 0.00
  • Stochastic Oscillator
  • MIST 80.00
  • NAAS 34.65

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.

Share on Social Networks: